Operating Cash Flow (Statement)

$1.13B

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$1.13Bperiod endingJun 30, 2026

VRTX Quarterly Cash from Operations (-$700.00K → $1.13B)

Quarterly operating cash flow (statement)

High-resolution chart · PNG

VRTX operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Operating Cash Flow (Statement) — Quarterly (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Jun 30, 2001	-2,747,000
Mar 31, 2001	-8,524,000
Dec 31, 2000	-13,823,000
Sep 30, 2000	-10,249,000
Jun 30, 2000	22,977,000
Mar 31, 2000	-15,549,000
Dec 31, 1999	9,200,000
Sep 30, 1999	-13,500,000
Jun 30, 1999	-12,600,000
Mar 31, 1999	-14,900,000
Dec 31, 1998	-10,800,000
Sep 30, 1998	1,000,000
Jun 30, 1998	-9,100,000
Mar 31, 1998	-12,200,000
Dec 31, 1997	-3,500,000
Sep 30, 1997	-2,800,000
Jun 30, 1997	-400,000
Mar 31, 1997	-2,700,000
Dec 31, 1996	-2,900,000
Sep 30, 1996	-6,900,000
Jun 30, 1996	-22,200,000
Mar 31, 1996	-8,300,000
Dec 31, 1995	300,000
Sep 30, 1995	-4,400,000
Jun 30, 1995	-6,900,000
Mar 31, 1995	-5,000,000
Dec 31, 1994	-5,400,000
Sep 30, 1994	-2,600,000
Jun 30, 1994	-3,200,000
Mar 31, 1994	-3,500,000
Dec 31, 1993	10,300,000
Sep 30, 1993	100,000
Jun 30, 1993	100,000
Mar 31, 1993	-1,900,000
Dec 31, 1992	-1,500,000
Sep 30, 1992	-1,400,000
Jun 30, 1992	-1,000,000
Mar 31, 1992	-1,400,000
Dec 31, 1991	-400,000
Sep 30, 1991	-700,000